v3.26.1
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Preferred Stock
Series A Convertible
Preferred Stock
Series B Convertible
Preferred Stock
Series C/C-1 Convertible
Common stock
Additional paid in capital
Accumulated deficit
Total
Balance at Dec. 31, 2023 $ 5,231 $ 13,701 $ 46,217 $ 5,732 $ (115,728) $ (109,996)
Balance (in Shares) at Dec. 31, 2023 4,350,314 5,293,175 8,220,445 25,844      
Stock-based compensation expense 21 21
Net loss (9,230) (9,230)
Balance at Dec. 31, 2024 $ 5,231 $ 13,701 $ 46,217 5,753 (124,958) (119,205)
Balance (in Shares) at Dec. 31, 2024 4,350,314 5,293,175 8,220,445 25,844      
Conversion of preferred stock into common stock $ (5,231) $ (13,701) $ (46,217) 65,149 65,149
Conversion of preferred stock into common stock (in Shares) (4,350,314) (5,293,175) (8,220,445) 82,377      
Common stock issued to employees 428 $ 428
Common stock issued to employees (in Shares)       6,363     6,363
Stock-based compensation expense 463 $ 463
Conversion of debt to common shares in connection with the merger 46,891 46,891
Conversion of debt to common shares in connection with the merger (in Shares)       197,098      
Issuance of common stock in connection with the merger and assumption of net liabilities of Northview (8,400) (8,400)
Issuance of common stock in connection with the merger and assumption of net liabilities of Northview (in Shares)       86,432      
Issuance of inducement shares to related party in connection with the merger 7,254 7,254
Issuance of inducement shares to related party in connection with the merger (in Shares)       38,691      
Issuance in shares in connection with exercise of ELOC 10,276 10,276
Issuance in shares in connection with exercise of ELOC (in Shares)       513,859      
Issuance of warrants in connection with exercise of ELOC Warrants 982 982
Issuance in shares in connection with exercise of ELOC Warrants
Issuance in shares in connection with exercise of ELOC Warrants (in Shares)       12,000      
Issuance of warrants to financial advisor in connection with the merger 330 330
Issuance of shares in connection with the conversion of the PIPE note 4,497 4,497
Issuance of shares in connection with the conversion of the PIPE note (in Shares)       266,055      
Issuance of shares for settlement of merger transaction costs 500 500
Issuance of shares for settlement of merger transaction costs (in Shares)       3,333      
Net loss (35,823) (35,823)
Balance at Dec. 31, 2025 $ 134,123 $ (160,781) $ (26,658)
Balance (in Shares) at Dec. 31, 2025       1,232,052